1027 Caris
BioCentury & Getty Images


Tumor profiling play Caris to grow biopharma partnerships with $310M round

Oct 27, 2020 | 11:39 PM GMT

With a newly raised $310 million in combined equity and debt, Caris plans to scale up its tumor profiling business and expand its biopharma partnerships. 

The round, which includes

Read the full 505 word article

How to gain access

Continue reading with a
two-week free trial.